Scarica l'app Stockscreener
21.18
5.27%
1.06
Dopo l'orario di chiusura:
21.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DYN Giù?
Forum
Previsione
Precedente Chiudi:
$20.12
Aprire:
$19.91
Volume 24 ore:
1.91M
Relative Volume:
0.73
Capitalizzazione di mercato:
$3.03B
Reddito:
-
Utile/perdita netta:
$-412.89M
Rapporto P/E:
-5.487
EPS:
-3.86
Flusso di cassa netto:
$-361.93M
1 W Prestazione:
+12.72%
1M Prestazione:
+26.45%
6M Prestazione:
+80.10%
1 anno Prestazione:
-28.76%
Intervallo 1D:
$19.67
$21.24
Intervallo di 1 settimana:
$18.42
$22.00
Portata 52W:
$6.36
$31.32
Dyne Therapeutics Inc Stock (DYN) Company Profile
Nome
Dyne Therapeutics Inc
Settore
Industria
Telefono
(781) 786-8230
Indirizzo
1560 TRAPELO ROAD, WALTHAM
Confronta DYN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
21.18 | 2.87B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-25 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | Iniziato | Bernstein | Mkt Perform |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-29 | Iniziato | Evercore ISI | Outperform |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-12-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-11-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-10-24 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-21 | Reiterato | Chardan Capital Markets | Buy |
| 2024-04-30 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-20 | Iniziato | H.C. Wainwright | Buy |
| 2023-02-27 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | Iniziato | Oppenheimer | Outperform |
| 2023-01-26 | Iniziato | Guggenheim | Buy |
| 2022-07-20 | Iniziato | Chardan Capital Markets | Buy |
| 2022-07-12 | Iniziato | Raymond James | Outperform |
| 2020-10-12 | Iniziato | JP Morgan | Overweight |
| 2020-10-12 | Iniziato | Jefferies | Buy |
| 2020-10-12 | Iniziato | Piper Sandler | Overweight |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Dyne Therapeutics Inc Borsa (DYN) Ultime notizie
Why Dyne Therapeutics Stock Was Crushing it This Week - The Globe and Mail
Will Dyne Therapeutics Inc. stock see PE expansionMarket Sentiment Summary & Verified Technical Trade Signals - newser.com
Why Dyne Therapeutics Inc. stock is favored by top institutions - newser.com
Can Dyne Therapeutics Inc. stock reach $100 price targetWall Street Watch & Low Drawdown Investment Ideas - newser.com
Is Dyne Therapeutics Inc. stock attractive for long term wealth buildingWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
Dyne Therapeutics Inc.’s volatility index tracking explained2025 Price Momentum & Low Risk Entry Point Guides - newser.com
Will Dyne Therapeutics Inc. stock deliver better than expected guidanceQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
Will Dyne Therapeutics Inc. stock go up soon2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Dyne Therapeutics Inc. reversing from oversold territoryIPO Watch & Reliable Breakout Forecasts - newser.com
Historical volatility pattern of Dyne Therapeutics Inc. visualized2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Dyne Therapeutics Inc. stock volume spike explainedInflation Watch & High Return Trade Guides - newser.com
Technical Reactions to DYN Trends in Macro Strategies - news.stocktradersdaily.com
Technical analysis overview for Dyne Therapeutics Inc. stock2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
Why Dyne Therapeutics Inc. stock is seen as undervalued2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
Dyne Therapeutics Inc Stock Analysis and ForecastHigh Dividend Yield Stocks & Outstanding Portfolio Tips - earlytimes.in
Baird Initiates Coverage of Dyne Therapeutics (DYN) with Outperform Recommendation - MSN
JP Morgan Maintains Dyne Therapeutics (DYN) Neutral Recommendation - Nasdaq
Dyne Therapeutics price target lowered to $17 from $18 at JPMorgan - MSN
JP Morgan Lowers Price Target for Dyne Therapeutics (DYN) | DYN Stock News - GuruFocus
What drives Dyne Therapeutics Inc stock priceLong-Term Investment Plans & Free Tap Rapid Wealth - earlytimes.in
How moving averages guide Dyne Therapeutics Inc. tradingJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com
Dyne Therapeutics Inc Azioni (DYN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):